Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This chapter focuses on the bioavailability of mineral compounds and the methodologies used to assess the bioavailability of microencapsulated mineral formulations. One of the well-known nutritional deficiencies for the treatment of which microencapsulated compounds have been extensively investigated in recent years is iron deficiency and iron deficiency anemia. The chapter mainly discusses methods and results of these investigations. Iron is a trace element which has a particular position among minerals for human nutrition: as there is no known excretion mechanism for iron in mammals, iron metabolism is regulated at the site of absorption and bioavailability is of paramount importance in maintaining iron balance. Methodologies to estimate, measure, and assess mineral bioavailability can be distinguished into four categories, listed in order of suitability for high throughput screening: in vitro methods with and without the use of Caco-2 cells; animal-based models; studies in human subjects using tracers; and double-blind, randomized controlled trials.

Original publication

DOI

10.1002/9781118946893.ch10

Type

Chapter

Book title

Encapsulation and Controlled Release Technologies in Food Systems: Second Edition

Publication Date

11/03/2016

Pages

289 - 308